You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

GRT-C903

Showing 1 - 25 of 1,260
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Non Small Cell Lung Cancer, Colorectal Cancer, Pancreatic Cancer Trial in United States (GRT-C903, GRT-R904, nivolumab)

Recruiting
  • Non-Small Cell Lung Cancer
  • +4 more
  • GRT-C903
  • +3 more
  • Phoenix, Arizona
  • +13 more
Jan 30, 2023

Colonic Tumors, Colorectal Tumors Trial in Detroit, New York, Cincinnati (GRT-C901, GRT-R902, Atezolizumab)

Recruiting
  • Colonic Neoplasms
  • Colorectal Neoplasms
  • Detroit, Michigan
  • +2 more
Aug 1, 2022

Colorectal Tumors Trial in United States (GRT-C901, GRT-R902, Atezolizumab)

Recruiting
  • Colorectal Neoplasms
  • Gilbert, Arizona
  • +46 more
Jan 31, 2023

Healthy Volunteer Trial (ABBV-903)

Not yet recruiting
  • Healthy Volunteer
  • (no location specified)
Aug 10, 2023

Non Small Cell Lung Cancer, Colorectal Cancer, Gastroesophageal Adenocarcinoma Trial in Australia, United States (GRT-C901,

Active, not recruiting
  • Non Small Cell Lung Cancer
  • +3 more
  • GRT-C901
  • +3 more
  • Phoenix, Arizona
  • +10 more
Aug 31, 2021

HIV-1-infection Trial in Lesotho, Tanzania (Clinical management informed by HIV-1 genotypic resistance testing)

Active, not recruiting
  • HIV-1-infection
  • Clinical management informed by HIV-1 genotypic resistance testing
  • Seboche, Butha-Buthe, Lesotho
  • +9 more
Dec 4, 2022

Malignant Glioma, Recurrent Glioma Trial in Beijing (personalized vaccine)

Recruiting
  • Malignant Glioma
  • Recurrent Glioma
  • personalized vaccine
  • Beijing, Beijing, China
    Xuanwu Hospital, Capital Medical University
Jun 26, 2021

COVID-19, SARS-CoV-2 Trial in Johannesburg, Pretoria (GRT-R912, samRNA-Spikebeta-TCE11, GRT-R914, samRNA-Spikebeta-TCE9,

Recruiting
  • COVID-19
  • SARS-CoV-2
  • GRT-R912, samRNA-Spikebeta-TCE11
  • +2 more
  • Johannesburg, South Africa
  • +1 more
Jun 24, 2022

Muscular Atrophy, Spinal Trial in Argentina, Brazil (OAV101)

Active, not recruiting
  • Muscular Atrophy, Spinal
  • OAV101
  • Caba, Buenos Aires, Argentina
  • +4 more
Oct 2, 2022

Multiple Myeloma Trial in Worldwide (No intervention)

Completed
  • Multiple Myeloma
  • No intervention
  • Buenos Aires, Argentina
  • +22 more
Aug 19, 2022

HIV-1-infection Trial in Argentina, Brazil (Intervention Arm: dolutegravir/lamivudine, Comparator ARM: TDF/XTC plus Dolutegravir

Recruiting
  • HIV-1-infection
  • Intervention Arm: dolutegravir/lamivudine
  • Comparator ARM: TDF/XTC plus Dolutegravir (XTC stand for lamivudine OR emtricitabine)
  • Ciudad Autonoma de Buenos Aire, Buenos Aires, Argentina
  • +7 more
Jun 29, 2022

Treatment Resistant Depression in America Latina

Completed
  • Depressive Disorder, Treatment-Resistant
    • Ciudad Autonoma de Buenos Aires, Argentina
    • +32 more
    Dec 8, 2021

    Microbial Colonization, Periodontal Diseases, Periodontal Inflammation Trial in Piracicaba (One-Stage Full Mouth Debridement,

    Recruiting
    • Microbial Colonization
    • +2 more
    • One-Stage Full Mouth Debridement
    • +4 more
    • Piracicaba, Sao Paulo, Brazil
      University of Campinas, UNICAMP
    May 25, 2021

    Breast Cancer Trial in Worldwide (Ipatasertib, Placebo, Palbociclib)

    Active, not recruiting
    • Breast Cancer
    • Atlanta, Georgia
    • +19 more
    Dec 5, 2022

    OTC Deficiency Trial in Worldwide (genetic, other, drug)

    Recruiting
    • OTC Deficiency
    • DTX301
    • +4 more
    • Aurora, Colorado
    • +19 more
    Jul 29, 2022

    Healthy Trial in Worldwide (Ad26.Mos4.HIV, Clade C and Mosaic gp140 HIV bivalent vaccine, Placebo)

    Active, not recruiting
    • Healthy
    • Ad26.Mos4.HIV
    • +2 more
    • Birmingham, Alabama
    • +52 more
    Jan 17, 2023

    Spinal Muscular Atrophy Trial in Italy, United States (Nusinersen)

    Recruiting
    • Spinal Muscular Atrophy
    • Phoenix, Arizona
    • +29 more
    Jan 20, 2023

    COVID-19 Trial in Birmingham, Leicester, Manchester (GRT-R910 10 mcg Dose (after AZ), GRT-R910 30 mcg Dose (after AZ), GRT-R910

    Recruiting
    • COVID-19
    • GRT-R910 10 mcg Dose (after AZ)
    • +3 more
    • Birmingham, United Kingdom
    • +2 more
    Aug 15, 2022

    Neurofibromatosis 1, Plexiform Neurofibroma (PN) Trial in Worldwide (Selumetinib, Placebo)

    Recruiting
    • Neurofibromatosis 1
    • Plexiform Neurofibroma (PN)
    • Gainesville, Florida
    • +40 more
    Jan 16, 2023

    Atopic Dermatitis Trial in Worldwide (Baricitinib, Placebo, Topical corticosteroid)

    Recruiting
    • Atopic Dermatitis
    • Caba, Buenos Aires, Argentina
    • +85 more
    Nov 4, 2022

    Prostate Cancer, Cardiovascular Disease Trial in Canada (Nutrition, Exercise, Smoking cessation)

    Recruiting
    • Prostate Cancer
    • Cardiovascular Disease
    • Nutrition
    • +4 more
    • Waratah, New South Wales, Australia
    • +37 more
    Oct 3, 2022

    Carbapenem-Resistant Enterobacteriaceae Infection, Bloodstream Infection, Severe Infection Trial in Brazil (Duration of therapy)

    Recruiting
    • Carbapenem-Resistant Enterobacteriaceae Infection
    • +9 more
    • Duration of therapy
    • Feira De Santana, Bahia, Brazil
    • +18 more
    Jan 27, 2022

    Non-alcoholic Steatohepatitis (NASH) Trial in Worldwide (No Intervention)

    Recruiting
    • Non-alcoholic Steatohepatitis (NASH)
    • No Intervention
    • Coronado, California
    • +47 more
    Aug 16, 2022

    Locally Advanced Cervical Cancer Trial in Worldwide (Volrustomig, Placebo)

    Recruiting
    • Locally Advanced Cervical Cancer
    • Volrustomig
    • Placebo
    • Savannah, Georgia
    • +85 more
    Oct 6, 2023

    Stroke, Atrial Fibrillation Trial in Canada, Denmark (Investigators can choose from one of four Non-vitamin K oral

    Recruiting
    • Stroke
    • Atrial Fibrillation
    • Non-vitamin K oral anticoagulant (NOAC)
    • Concord, New South Wales, Australia
    • +46 more
    Oct 21, 2022